Get 50% OFF This Summer!
Balaji Amines
No Data Available
Investor Sentiment
Balaji Amines Share price and Fundamental Analysis
Key Metrics
Included In
Stock Returns
CAGR
Revenue Growth
Net Profit Growth
Operating Profit Growth
Dividend Growth
Stock Returns CAGR
Stock Heatmap
No Stocks
Smart Score
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
Technicals
Returns Calculator
If you would have investedResearch Report
No Research Report
Corporate Action
Financials
Key Ratios
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
Dividend History
5 Year FactSheet
Documents
No Data Available
News
Balaji Amines Management and History
Company Management
Unlock Management Data
See Detailed Analysis & Insights
Company History
Promoted by the KPR Group of Industries, Balaji Amines Ltd. (BAL) was incorporated on 27th October, 1988. The Company is a leading manufacturer of ethyl and methyl amines which have various applications in chemical industries. It is presently engaged in manufacture and sale of Speciality Chemicals, Aliphatic Amines and Derivatives. Apart from this, it has now diversified into producing derivatives of methyl and ethyl amines, namely, Di-Methyl Amine Hydrochloride (DMA-HCl), Choline Chloride, Di Methyl Acetamide, etc. At present, the Company supply to various Blue Chip Companies like IDI, Hoechst, Rallis, Ion Exchange, Cheminor Drugs, TTK Pharma, etc.
It has four manufacturing facilities, three plants at Tuljapur and Chincholi in Maharashtra and one at Medak, Telangana. It owns a Five Star Hotel in Solapur, Maharashtra and has CFL lamps facility at Medak, Telangana. The Company presently operates in three segments i.e., Specialty Chemicals and Amines, Hotel and CFL Lamps. A new facility for manufacture of Speciality Chemicals is under construction at Chicholi, Maharashtra.
On May '95, it came out with a public issue of 9.63 lac equity shares (premium : Rs 30), aggregating Rs 3.85 cr to part-finance expansion plans for ethylamines and forward integration for the manufacture of derivatives of methyl and ethyl amines, totaling to Rs 10 cr.
In 1988, the Company started business operations.
In 1989, it started to produce Methyl Amines and Ethyl Amines.
In 1992, the Company established R&D Centre at Hyderabad.
In 1995, it started manufacturing drug intermediate -Dimethyl Amine Hydrochloride.
In 1997-98, the company has successfully commenced the commercial operation of its main plant (Ethyl Amines) from June, 1997.
In 2000, it added derivatives of Methyl and Ethyle Amines to the product portfolio.
In 2001, the Company was certified with ISO:9001.
Expansion programme has been taken up for value-added products like Choline Chloride, DMAE-HCI and other intermediates at a cost of Rs.500 lacs. The project has been appraised by State Bank of Hyderabad and Bank of India for a term loan of Rs.290 lacs and Rs.100 lacs respectively.The balance would be met out by the internal accruals of the company.The project would be implemented on phases and the first phase is likely to be commissioned during the current year 2001-2002.
During the year 2003, Company was awarded 'Recognized Export House' status from Government of India, Ministry of Commerce, New Delhi. It increased the capacity of Methyl Amines.
In 2005, the Company developed more specialty chemicals.
In 2006, it founded Balaji Foundation and Research Centre for the rural population as a part of CSR activity. It became the sole manufacturer of GBI, NMP, and Morpholine.
During the year 2009, the Company started power generation through windmill by establishing 1.5 MW windmill unit at Satara, Maharashtra. It established an R & D GBL Plant at Tamalwadi, Solapur. It commenced setting up 2.5 MW Co-Generation Power Plant Unit at Tamalwadi and PVP Plant at Chincholi, in Solapur respectively. Apart from this, it secured the Certificate of Merit' for Outstanding Export by Chemexcil.
During the year 2010, 2.5 Mw Co- Generation Power Plant at Tamalwadi, Solapur has been commissioned in July, 2009. Besides this, the PVP Plant at Chincholi, Solapur has started producing various grades and the mandatory approvals are in final stages.
In 2010, the Company installed wind turbine for generating in-house electricity to start focusing on renewable energy.
In 2012, the Company received 'Certificate of Suitability' certification from European Directorate for the Quality Medicines & Health Care (EDQM), Europe for its product PVPK-30. It also received WHOGMP certification and REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) for four products namely, Triethylamine, Gammabutyrolactone, N-Ethylamine-2-Pyrrolidone along with the already registered N-methyl 2 Pyrrolidone (NMP). It has been awarded for the category of 'Best Manufacturer - Exporter (Medium)' at the Indian Exporter Excellence Awards 2012 instituted by the Export Credit Guarantee Corporation of India Limited (ECGC)[An Indian Govt. Undertaking], in association with Dun and Bradstreet (D&B), which seeks to recognize leading exporters for their excellence in their respective fields.
In October 2013, the Company inaugurated its 129 Room Five-Star Hotel Property Balaji Sarovar Premiere' with an investment of Rs. 110 crore. It executed the commissioning of DMF manufacturing Plant. Further, two new plants, one for the first phase of Di-Methyl Amine Hydrochloride (DMA-HCL) with an installed capacity of 7500 MT per annum commissioned in the month of February, 2013 and second plant for manufacture of Di Methyl Formamide (DMF) with an installed capacity of 30000 MT / P. A at MIDC Chincholi, Solapur has been commissioned in the month of March, 2013.
During the year 2013, Company's 5 star Hotel Property started commercially from 1st November 2013 which is being managed by Sarovar Group of Hotels.
In 2014, the Company was awarded for Balaji Sarovar Premium's eco-friendly Green technology'.
During the year 2015, Company successfully re-commissioned its DMF plant by strengthening the Carbon Monoxide plan. In 2015, it was awarded another Certificate of Excellence' for Balaji Sarovar Premiere from the Trip Advisor on the basis of customer reviews for excellent food, service and hospitality.
In 2016, it set up a plant to manufacture Acetonitrile.
During the year 2017-18, the subsidiaries of the Company viz. Bhagyanagar Chemicals Limited (company's holding 100%) and Balaji Greentech Products Limited (company's holding 66%) were amalgamated with BAL (the Company) as per the scheme of amalgamation sanctioned by the Hon'ble NCLT, Mumbai.
In 2018, the Company was 90 acres of land at MIDC, Chincholi with Mega Project Status for this new project by Maharashtra State Government. It commissioned a new plant for manufacture of Morpholine and Acetonitrile after successful trial runs.
In 2019, the Company set up a new plant project under its subsidiary, Balaji Specialty Chemicals Private Limited, which got completed in a record 12 months.
In 2021, Company commenced operation in Greenfield Project at Unit-IV. The Boiler of 50 TPH capacity was commissioned during FY 2021-22, with a capex of Rs 19.76 Crores. The Company commissioned a New Ethylamines Plant Phase I of its Greenfield Project.
During FY 23, the Company commissioned Phase I (Unit IV) DMC, PG and PC plants, comprising the production capacity of 15,000 tons of Di-methyl Carbonate (DMC)/ Propylene Carbonate (PC) and 15,000 tons of Propylene Glycol (PG).
Balaji Amines Share Price
Balaji Amines share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Balaji Amines Market Cap
Market capitalization of Balaji Amines indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Balaji Amines is valued compared to its competitors.
Balaji Amines PE Ratio
Balaji Amines PE ratio helps investors understand what is the market value of each stock compared to Balaji Amines 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
Balaji Amines PEG Ratio
The PEG ratio of Balaji Amines evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Balaji Amines ROE (Return on Equity)
Return on Equity (ROE) measures how effectively Balaji Amines generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Balaji Amines ROCE (Return on Capital Employed)
Return on Capital Employed (ROCE) evaluates the profitability of Balaji Amines in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Balaji Amines Total Debt
Total debt of Balaji Amines shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
Balaji Amines Debt to Equity Ratio
The Debt-to-Equity (DE) ratio of Balaji Amines compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
Balaji Amines CAGR (Compound Annual Growth Rate)
CAGR shows the consistent growth rate of Balaji Amines over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Balaji Amines Technical Analysis
Technical analysis of Balaji Amines helps investors get an insight into when they can enter or exit the stock. Key components of Balaji Amines Technical Analysis include:
Support Levels (S1, S2, S3)
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
Resistance Levels (R1, R2, R3)
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Balaji Amines shares often struggle to rise above due to selling pressure.
Balaji Amines Dividends
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Balaji Amines ’s financial health and profitability.
Balaji Amines Bonus Shares
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Balaji Amines Stock Split
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
Balaji Amines Financials
The financials of Balaji Amines provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
Balaji Amines Profit and Loss Statements
The profit and loss statement of Balaji Amines highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Balaji Amines .
Balaji Amines Balance Sheet
The balance sheet presents a snapshot of Balaji Amines ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Balaji Amines Cashflow Statements
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App
SEBI REGISTERED RESEARCH ANALYST REGISTRATION NUMBER: INH000015729Disclaimer: "Investments in securities are subject to market risks. Read all the related documents carefully before investing." Receiving registration from SEBI and certification from NISM does not assure the performance of the intermediary or guarantee returns to investors in any manner. Compliance Email: [email protected]
Features
Portfolio Analysis
Screener
Stock compare
Buckets
Watchlist
Superstar Portfolio
Market
List of BSE200 Companies
List of NIFTY500 Companies
List of NIFTY NEXT 50 Companies
NIFTY Top gainers in 5 Days
NIFTY100 Most Active Stocks
NIFTY Top Gainers in 1 Month